1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > United States Genetic Testing Market Outlook to 2021

United States Genetic Testing Market Outlook to 2021

  • August 2015
  • -
  • GlobalData
  • -
  • 110 pages

Summary

Table of Contents

Search Inside

United States Genetic Testing Market Outlook to 2021

Summary

GlobalData’s new report, "United States Genetic Testing Market Outlook to 2021", provides key market data on the United States Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the United States Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the ...

The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

  • $ 5495
  • Industry report
  • March 2017
  • by Howe Sound Research

“Genomic Discoveries and Direct to Consumer Drive Growth in a New Genetic Testing Industry....” Will all newborns receive Whole Genomic Sequencing at birth? How fast will Direct to Consumer Testing ...

Global Direct-to-Consumer (DTC) Genetic Testing - Clinical Diagnostics

Global Direct-to-Consumer (DTC) Genetic Testing - Clinical Diagnostics

  • $ 4950
  • Industry report
  • March 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Direct-to-Consumer (DTC) Genetic Testing in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, ...


Download Unlimited Documents from Trusted Public Sources

Obesity Statistics in the Netherlands

  • April 2017
    177 pages
  • Obesity  

    Genetic  

    Type 2 Diabetes  

  • Netherlands  

View report >

Genetic Industry in Europe

  • April 2017
    15 pages
  • Genetic  

  • Europe  

View report >

Genetic Industry in the UK

  • April 2017
    9 pages
  • Genetic  

  • United Kingdom  

View report >

Genetic Industry

22 days ago

Fig Industry In Kenya

1 month ago

Related Market Segments :

Genetic
Nanobiotechnology
Diagnostics

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.